Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2023-Q3
добавлен 13.11.2023
Eloxx Pharmaceuticals Мультипликаторы 2011-2024 | ELOX
Мультипликаторы по годам Eloxx Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.2 | -0.0 | -4.0 | -2.9 | -7.9 | -1.1 | -0.4 | -0.6 | -1.2 | -0.7 | -4.4 | -2.5 |
P/S |
- | - | - | - | - | - | 48.8 | 142.2 | 113.9 | - | 111.4 | - |
EPS |
-16.6 | -38.1 | -0.9 | -1.3 | -1.4 | -4.8 | -2.6 | 1.7 | -2.5 | -5.1 | -7.8 | -0.1 |
EV (Enterprise Value) |
18.7 млн | -18.3 млн | 130 млн | 149 млн | 333 млн | -12.6 млн | 6.11 млн | 14.7 млн | 11.1 млн | 5.81 млн | 23.8 млн | 18.5 млн |
EBITDA per Share |
-15.8 | -37.7 | -0.832 | -1.31 | -1.44 | -1.81 | -3.56 | -10.6 | -24.1 | -62.8 | -113 | -178 |
EV/EBITDA |
0.3 | -3.6 | -2.8 | -7.0 | -3.3 | -0.8 | -1.0 | -0.8 | -1.1 | -4.7 | -2.7 | |
PEG |
-0.0 | -0.0 | -0.11 | -0.39 | -0.11 | -0.03 | -0.01 | -0.01 | -0.02 | -0.02 | -0.1 | -0.03 |
P/B |
-0.6 | 0.1 | 13.5 | 4.1 | 8.7 | 7.5 | 0.8 | 0.9 | 0.4 | 1.1 | 6.5 | 4.0 |
P/CF |
-0.2 | -0.0 | -4.9 | -3.8 | -11.8 | -3.4 | -1.0 | -1.4 | -2.1 | -0.9 | -4.6 | -3.0 |
ROE % |
338.32 | -298.10 | -338.00 | -140.49 | -109.96 | -665.33 | -181.29 | -147.76 | -33.56 | -161.71 | -146.72 | -160.91 |
ROA % |
-170.74 | -147.83 | -130.59 | -86.30 | -93.03 | -99.16 | -89.62 | -92.41 | -27.67 | -86.26 | -72.84 | -84.55 |
ROCE % |
322.88 | -294.93 | -201.06 | -107.24 | -109.46 | -69.76 | -41.93 | -40.83 | -21.97 | -118.03 | -134.26 | -118.81 |
Current Ratio |
0.7 | 2.0 | 2.6 | 4.9 | 6.4 | 0.1 | 2.7 | 4.8 | 4.0 | 1.1 | 1.1 | 1.5 |
DSO |
- | - | - | - | - | - | - | - | 157.4 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Eloxx Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.31 | -1.96 | -2.88 | - | -3.47 | -4.9 | -5.36 | - | -0.11 | -0.54 | -0.22 | - | -0.16 | -0.2 | -0.35 | - | -0.32 | -0.4 | -0.33 | - | -0.32 | -0.42 | -0.31 | - | -1.15 | -1.04 | -0.03 | -0.04 | -0.05 | -0.08 | -0.15 | -0.19 | -0.02 | -0.19 | -0.02 | -0.78 | -0.38 | -0.78 | -0.38 | -0.48 | -0.78 | -0.48 | -0.78 | -1.11 | -2.52 | -0.01 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 |
EBITDA per Share |
- | - | -2.52 | - | -3.29 | -4.74 | -5.05 | - | -0.12 | -0.54 | -0.21 | - | -0.16 | -0.19 | -0.34 | - | -0.32 | -0.39 | -0.33 | - | -0.32 | -0.42 | -0.31 | - | -0.95 | -0.75 | -0.01 | -0.07 | -0.11 | -0.18 | -0.24 | -0.18 | -0.06 | -0.18 | -0.06 | -0.78 | -0.37 | -0.77 | -0.37 | -0.44 | -0.73 | -0.42 | -0.73 | -1.05 | -1.1 | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
ROE % |
153.73 | 286.51 | -322.81 | -534.72 | -564.67 | -745.33 | -248.07 | -434.82 | -499.50 | -534.23 | -522.61 | -278.10 | -313.66 | -284.53 | -247.33 | -108.36 | -134.37 | -124.83 | -116.17 | -77.27 | -126.89 | -119.80 | -106.71 | -92.62 | -172.48 | -179.31 | -221.79 | -236.33 | -706.45 | -682.15 | -665.70 | -646.71 | -434.36 | -456.03 | -501.84 | -519.22 | -152.95 | -214.11 | -166.88 | -195.15 | -254.50 | -249.54 | -243.54 | -256.81 | -230.40 | -177.50 | -174.54 | -137.15 | -26.42 | -33.81 | -23.00 |
ROA % |
-246.35 | -214.83 | -174.63 | -86.81 | -104.65 | -94.57 | -121.83 | -120.03 | -145.02 | -152.16 | -122.46 | -107.45 | -129.29 | -126.14 | -120.87 | -66.57 | -88.58 | -88.74 | -90.66 | -65.38 | -108.15 | -102.44 | -91.66 | -79.83 | -62.31 | -59.32 | -73.36 | -78.36 | -77.76 | -65.37 | -55.42 | -46.22 | -79.50 | -96.99 | -109.50 | -124.13 | -80.80 | -93.06 | -83.64 | -93.23 | -101.89 | -104.51 | -99.95 | -104.80 | -103.83 | -83.08 | -82.59 | -64.69 | -12.56 | -17.77 | -12.09 |
ROCE % |
150.11 | 275.32 | -315.15 | -518.58 | -549.63 | -724.03 | -243.73 | -424.92 | -486.46 | -516.96 | -503.21 | -270.27 | -305.56 | -279.31 | -244.67 | -107.88 | -134.35 | -125.54 | -117.58 | -77.95 | -96.68 | -88.93 | -72.25 | -36.55 | -283.67 | -325.92 | -441.84 | -546.10 | -883.44 | -831.68 | -743.95 | -646.16 | -448.98 | -462.90 | -509.84 | -519.28 | -152.58 | -212.23 | -164.19 | -191.62 | -253.27 | -217.88 | -213.57 | -203.36 | -172.52 | -157.68 | -152.26 | -144.51 | -32.55 | -32.23 | -28.34 |
Current Ratio |
0.2 | 0.2 | 0.3 | 0.7 | 0.8 | 1.1 | 1.4 | 2.0 | 2.5 | 3.0 | 1.2 | 1.6 | 1.6 | 1.6 | 1.6 | 2.6 | 2.6 | 2.6 | 2.6 | 6.5 | - | - | - | - | 7.6 | 5.0 | 7.6 | 1.1 | 2.1 | 1.2 | 2.0 | 2.3 | 2.8 | 2.7 | 2.7 | 2.8 | 4.9 | 5.7 | 5.7 | 3.3 | 1.6 | 2.1 | 2.1 | 1.4 | 1.7 | 2.0 | 2.0 | 1.7 | 1.9 | 2.1 | 2.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD